NASDAQ:ODTX

Odyssey Therapeutics Q2 2026 Earnings Results & Report

$19.36 +0.22 (+1.15%)
As of 04:00 PM Eastern

Odyssey Therapeutics reported Q2 2026 earnings on August 5, 2026. The company reported EPS of -$1.74.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
Before Market Opens
Conference Call Date
Conference Call
7:00 AM ET

Odyssey Therapeutics EPS Results

Actual EPS
-$1.74
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Odyssey Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Odyssey Therapeutics Q2 2026 Earnings FAQ

Odyssey Therapeutics (NASDAQ:ODTX) reported earnings of -$1.74 per share for Q2 2026. The report was announced on Wednesday, August 5, 2026.

Odyssey Therapeutics Earnings Headlines

What is HC Wainwright's Estimate for ODTX FY2026 Earnings?
Your Copy is on Hold (Claim it now)
James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play. He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60. Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date.tc pixel
What is HC Wainwright's Forecast for ODTX Q1 Earnings?
See More Odyssey Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Odyssey Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Odyssey Therapeutics and other key companies, straight to your email.

About Odyssey Therapeutics

Odyssey Therapeutics (NASDAQ:ODTX) is a biotechnology company focused on discovering and developing medicines for inflammatory and autoimmune diseases. Its research centers on the immune system and biological pathways that may be targeted to address these conditions.

Founded in 2021, the company uses drug-discovery capabilities to identify and advance potential therapies. Its business is research and development rather than the sale of marketed medicines.

Odyssey is based in the United States. As a research-focused biotechnology company, its activities are centered on developing potential treatments rather than serving patients through a broad commercial product operation.

View Odyssey Therapeutics Profile